15 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status
6-K
EX-99.6
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
, our mission is to transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those
DRS/A
EX-10.12
AMYT
Amryt Pharma Plc
11 May 20
Draft registration statement (amended)
12:00am
Introduction
At Aegerion, we have an important mission – the development and commercialization of innovative therapeutics to treat debilitating and rare
F-1
EX-10.12.5
AMYT
Amryt Pharma Plc
23 Jun 20
Registration statement (foreign)
5:21pm
Introduction
At Aegerion, we have an important mission – the development and commercialization of innovative therapeutics to treat debilitating and rare
F-1
AMYT
Amryt Pharma Plc
8 Jan 21
Registration statement (foreign)
4:58pm
development and commercialization capabilities.
Our Strategy
Our mission is to become a global leader in the treatment of rare diseases through … commercializing, developing and acquiring novel rare disease products. To achieve this mission, we are pursuing the following strategies:
Drive revenue growth
424B4
hlk8j6uslm
8 Jul 20
Prospectus supplement with pricing info
4:05pm
DRS
xg56ed4 173xnyo97xi7
19 Feb 20
Draft registration statement
12:00am
DRS
ovun4p9i
18 Dec 20
Draft registration statement
12:00am
F-1
2lu slehta
23 Jun 20
Registration statement (foreign)
5:21pm
F-1/A
7mwq dc6k
12 Jan 21
Registration statement (foreign) (amended)
12:00am
DRS/A
f3a794 h9
29 May 20
Draft registration statement (amended)
12:00am
F-1/A
jd4uey l8ig119n
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
424B4
jhb 87evlyy9vdj
14 Jan 21
Prospectus supplement with pricing info
9:30am
20-F
w6tuw3 loes4gmhvldo
30 Apr 21
Annual report (foreign)
12:53pm
- Prev
- 1
- Next